Type 2 diabetes is a disease in which your pancreas does not produce enough insulin, or your body does not properly use the insulin it makes, both of which can lead to uncontrolled blood sugar levels. A proof-of-concept Phase II clinical trial with DM-99 demonstrated that blood glucose levels were reduced by up to 48% following the consumption of a meal.